Isothermal Nucleic Acid Amplification Technology Market by Product (Assay, System), Technology (LAMP, SDA, NASBA, NEAR, HDA), Application (Diagnostics (Influenza, Hepatitis, CT/NG, COVID-19), blood screening), End User & Region - Global Forecast to 2028
The isothermal nucleic acid amplification technology market is projected to reach USD 6.8 Billion by 2028 from USD 4.4 Billion in 2023, at a CAGR of 9.2% during the forecast period. Increasing prevalence of infectious diseases, launches & approvals for INAAT products and availability of funding for diagnostic tools are various factors projected to drive the growth of the isothermal nucleic acid amplification technology market.
LAMP segment accounted for the largest share of the INAAT market
Based on technology, the isothermal nucleic acid amplification technology market is segmented into loop-mediated isothermal amplification (LAMP), transcription-mediated amplification (TMA), strand displacement amplification (SDA), nicking enzyme amplification reaction (NEAR), single-primer isothermal amplification (SPIA), and other technologies. In 2022, the loop-mediated isothermal amplification (LAMP) segment dominated the market. This is owing to high demand for LAMP kits and wide availability of these kits in developed and developing markets across the globe.
Infectious disease diagnosis segment accounted for the largest application segment of the market
Based on application, the INAAT market is segmented into infectious disease diagnosis, blood screening, and other applications. The disease diagnosis segment is expected to dominate the market in 2022. Various factors drive the growth of the segment are rising number of HIV, influenza, and hepatitis cases across the globe, focus on infectious disease control, and use of INAAT based kits for the diagnosis of these diseases.
The prominent players in isothermal nucleic acid amplification technology market are Grifols, S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), Eiken Chemical Co., Ltd. (Japan), bioM?rieux SA (France), Tecan Trading AG (Switzerland), New England Biolabs (US), QIAGEN N.V. (Germany), DiaSorin S.p.A. (Italy), General Electric (US), OptiGene Limited (UK), Quidel Corporation (US), Thermo Fisher Scientific (US), Genomtec (Poland), Mast Group Ltd. (UK), Ustar Biotechnologies (China), Jena Bioscience GmbH (Germany), Atila BioSystems (US), TwistDx Limited (UK), LGC Limited (UK), Life Sciences Advanced Technologies (US), GenoSensor Corporation (US), and PCR Biosystems (UK).?
“North America: Accounted for the largest share in isothermal nucleic acid amplification technology market”
North America has the largest share of the isothermal nucleic acid amplification technology market. Factors such as availability of research funding and the development of diagnostic industry, increasing importance of early diagnosis for patient with HIV, Hepatitis and Influenza, and developed healthcare infrastructure are the major factors driving the market growth.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the isothermal nucleic acid amplification technology market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end users and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall isothermal nucleic acid amplification technology market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.
LAMP segment accounted for the largest share of the INAAT market
Based on technology, the isothermal nucleic acid amplification technology market is segmented into loop-mediated isothermal amplification (LAMP), transcription-mediated amplification (TMA), strand displacement amplification (SDA), nicking enzyme amplification reaction (NEAR), single-primer isothermal amplification (SPIA), and other technologies. In 2022, the loop-mediated isothermal amplification (LAMP) segment dominated the market. This is owing to high demand for LAMP kits and wide availability of these kits in developed and developing markets across the globe.
Infectious disease diagnosis segment accounted for the largest application segment of the market
Based on application, the INAAT market is segmented into infectious disease diagnosis, blood screening, and other applications. The disease diagnosis segment is expected to dominate the market in 2022. Various factors drive the growth of the segment are rising number of HIV, influenza, and hepatitis cases across the globe, focus on infectious disease control, and use of INAAT based kits for the diagnosis of these diseases.
The prominent players in isothermal nucleic acid amplification technology market are Grifols, S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), Eiken Chemical Co., Ltd. (Japan), bioM?rieux SA (France), Tecan Trading AG (Switzerland), New England Biolabs (US), QIAGEN N.V. (Germany), DiaSorin S.p.A. (Italy), General Electric (US), OptiGene Limited (UK), Quidel Corporation (US), Thermo Fisher Scientific (US), Genomtec (Poland), Mast Group Ltd. (UK), Ustar Biotechnologies (China), Jena Bioscience GmbH (Germany), Atila BioSystems (US), TwistDx Limited (UK), LGC Limited (UK), Life Sciences Advanced Technologies (US), GenoSensor Corporation (US), and PCR Biosystems (UK).?
“North America: Accounted for the largest share in isothermal nucleic acid amplification technology market”
North America has the largest share of the isothermal nucleic acid amplification technology market. Factors such as availability of research funding and the development of diagnostic industry, increasing importance of early diagnosis for patient with HIV, Hepatitis and Influenza, and developed healthcare infrastructure are the major factors driving the market growth.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 80% and Demand Side - 20%
- By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%
- By Region: North America -20%, Europe -15%, Asia-Pacific -55%, RoW -10%
- Grifols, S.A. (Spain)
- Hologic, Inc. (US)
- Abbott Laboratories (US)
- Becton, Dickinson and Company (US)
- Meridian Bioscience (US)
- Eiken Chemical Co., Ltd. (Japan)
- bioM?rieux SA (France)
- Tecan Trading AG (Switzerland)
- New England Biolabs (US)
- QIAGEN N.V. (Germany)
- DiaSorin S.p.A. (Italy)
- General Electric (US)
- OptiGene Limited (UK)
- Quidel Corporation (US)
- Thermo Fisher Scientific (US)
- Genomtec (Poland)
- Mast Group Ltd. (UK)
- Ustar Biotechnologies (China)
- Jena Bioscience GmbH (Germany)
- Atila BioSystems (US)
- TwistDx Limited (UK)
- LGC Limited (UK)
- Life Sciences Advanced Technologies (US)
- GenoSensor Corporation (US)
- PCR Biosystems (UK)
This report provides a detailed picture of the isothermal nucleic acid amplification technology market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end users and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall isothermal nucleic acid amplification technology market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 PRIMARY RESEARCH
FIGURE 3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: PRIMARY RESPONDENTS
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY RESOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: CAGR PROJECTIONS, 2023–2028
FIGURE 8 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
2.4 DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT
3 EXECUTIVE SUMMARY
FIGURE 10 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 11 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 12 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 13 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET
4 PREMIUM INSIGHTS
4.1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET OVERVIEW
FIGURE 15 INCREASING PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT AND COUNTRY (2022)
FIGURE 16 ASSAYS, KITS, AND REAGENTS ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SHARE, BY APPLICATION, 2023 VS. 2028
FIGURE 17 DISEASE DIAGNOSIS APPLICATION SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028
4.4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Recent launches of INAAT consumables by prominent market players
5.2.1.2 Growing funding initiatives for molecular diagnostics & infectious disease diagnostics
5.2.1.3 High prevalence of infectious diseases
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable reimbursement scenario for in vitro diagnostic tests
5.2.3 OPPORTUNITIES
5.2.3.1 INAAT tests as point-of-care tools
5.2.3.2 Start-ups focusing on INAAT
5.2.4 CHALLENGES
5.2.4.1 Dominance of PCR
5.3 PRICING ANALYSIS
TABLE 2 AVERAGE SELLING PRICE OF INAAT PRODUCTS, 2022
5.4 VALUE CHAIN ANALYSIS
FIGURE 20 VALUE CHAIN OF INAAT MARKET: MAXIMUM VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.5 ECOSYSTEM ANALYSIS
FIGURE 21 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS
TABLE 3 SUPPLY CHAIN ECOSYSTEM
5.6 KEY CONFERENCES & EVENTS IN 2023–2024
TABLE 4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 5 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT FROM NEW ENTRANTS
5.7.2 THREAT FROM SUBSTITUTES
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 BARGAINING POWER OF SUPPLIERS
5.7.5 DEGREE OF COMPETITION
5.8 KEY STAKEHOLDERS & BUYING CRITERIA
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF INAAT PRODUCTS
FIGURE 23 BUYING CRITERIA FOR INAAT PRODUCTS
5.9 PATENT ANALYSIS
FIGURE 24 PATENT APPLICATIONS RELATED TO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, JANUARY 2012–DECEMBER 2022
5.10 REGULATORY ANALYSIS
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10.1 NORTH AMERICA
5.10.1.1 US
5.10.1.2 Canada
5.10.2 EUROPE
TABLE 10 EUROPE: CLASSIFICATION OF DEVICES
5.10.3 ASIA PACIFIC
5.10.3.1 China
5.10.3.2 Japan
5.10.3.3 India
5.10.4 LATIN AMERICA
5.10.4.1 Brazil
5.10.4.2 Mexico
5.10.5 MIDDLE EAST
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 25 REVENUE SHIFT AND NEW REVENUE POCKETS
6 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 11 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 ASSAYS, KITS, AND REAGENTS
6.2.1 GROWING AWARENESS OF INAAT TO DRIVE DEMAND FOR ASSAYS, KITS, AND REAGENTS
TABLE 12 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 13 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 14 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 15 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 SYSTEMS
6.3.1 GROWING POPULARITY OF INAAT SYSTEMS TO SUPPORT MARKET GROWTH
TABLE 16 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 17 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 20 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGIES
TABLE 21 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
7.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP)
7.2.1 LAUNCH OF NEW LAMP DIAGNOSTIC KITS TO SUPPORT MARKET GROWTH
TABLE 22 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 23 NORTH AMERICA: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 EUROPE: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 ASIA PACIFIC: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)
7.3.1 GROWING EFFORTS TO DEVELOP TMA KITS TO BOOST GROWTH
TABLE 26 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 27 NORTH AMERICA: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 EUROPE: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 29 ASIA PACIFIC: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 NICKING ENZYME AMPLIFICATION REACTION (NEAR)
7.4.1 RAPID IDENTIFICATION OF SMALL DNA OR RNA FRAGMENTS TO BOOST ADOPTION OF NEAR
TABLE 30 NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 31 NORTH AMERICA: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 EUROPE: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 ASIA PACIFIC: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 STRAND DISPLACEMENT AMPLIFICATION (SDA)
7.5.1 GROWING USE OF SDA IN RNA AMPLIFICATION TO PROPEL MARKET GROWTH
TABLE 34 STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 EUROPE: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 ASIA PACIFIC: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.6 HELICASE-DEPENDENT AMPLIFICATION (HDA)
7.6.1 USE OF THERMOSTABLE HELICASE ENZYMES INSTEAD OF HEAT TO BOOST DEMAND FOR HDA
TABLE 38 HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 EUROPE: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 ASIA PACIFIC: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.7 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA)
7.7.1 ADVANTAGES OF NASBA OVER PCR TO BOOST ADOPTION IN CLINICAL SETTINGS
TABLE 42 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 EUROPE: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 ASIA PACIFIC: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.8 SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA)
7.8.1 USE OF RNA/DNA-3? PRIMER FOR FIRST-STRAND CDNA SYNTHESIS TO DRIVE MARKET
TABLE 46 SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 47 NORTH AMERICA: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 EUROPE: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 ASIA PACIFIC: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.9 OTHER TECHNOLOGIES
TABLE 50 OTHER INAAT TECHNOLOGIES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 51 NORTH AMERICA: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 EUROPE: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 ASIA PACIFIC: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 54 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 DISEASE DIAGNOSIS
TABLE 55 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 56 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 57 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 59 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.1 COVID-19
8.2.1.1 Extensive use of INAAT kits for COVID-19 diagnosis to support market growth
TABLE 60 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY REGION, 2021–2028 (USD MILLION)
TABLE 61 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.2 HEPATITIS
8.2.2.1 Growing adoption of advanced technologies for diagnosis of hepatitis B to drive growth
FIGURE 26 NEW CASES OF HEPATITIS B AND HEPATITIS C WORLDWIDE, BY GENDER, 2020
TABLE 64 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY REGION, 2021–2028 (USD MILLION)
TABLE 65 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.3 CT/NG
8.2.3.1 Growing prevalence of CT/NG infections worldwide to boost market
TABLE 68 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY REGION, 2021–2028 (USD MILLION)
TABLE 69 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.4 INFLUENZA
8.2.4.1 Growing focus on containing spread of influenza to propel growth
TABLE 72 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY REGION, 2021–2028 (USD MILLION)
TABLE 73 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.5 HIV
8.2.5.1 High global incidence of HIV to support market growth
TABLE 76 GLOBAL HIV CASES, 2021
TABLE 77 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY REGION, 2021–2028 (USD MILLION)
TABLE 78 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.6 OTHER DISEASES
TABLE 81 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2021–2028 (USD MILLION)
TABLE 82 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 BLOOD SCREENING
8.3.1 INCREASING NUMBER OF BLOOD DONATIONS AND TRANSFUSIONS TO INCREASE USE OF INAAT IN BLOOD SCREENING APPLICATIONS
TABLE 85 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 86 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 OTHER APPLICATIONS
TABLE 89 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 90 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 91 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 92 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
9 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER
9.1 INTRODUCTION
TABLE 93 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 HOSPITALS
9.2.1 HOSPITALS TO DOMINATE INAAT MARKET DURING FORECAST PERIOD
TABLE 94 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION)
TABLE 95 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 96 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 97 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 REFERENCE LABORATORIES
9.3.1 AVAILABILITY OF WIDE RANGE OF TEST PANELS FOR INFECTIOUS DISEASE TESTING TO SUPPORT MARKET
TABLE 98 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 99 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 ACADEMIC & RESEARCH INSTITUTES
9.4.1 GROWING USE OF INAAT ASSAYS BY ACADEMIC & RESEARCH INSTITUTES TO BOOST MARKET
TABLE 102 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 103 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 OTHER END USERS
TABLE 106 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 107 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 108 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 109 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
10 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION
10.1 INTRODUCTION
TABLE 110 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SNAPSHOT
TABLE 111 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 112 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 113 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 114 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 115 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 116 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 Increasing approvals of INAAT products to drive market growth
TABLE 117 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 118 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 119 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 120 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Growing demand for molecular diagnostic kits to boost adoption of INAAT
TABLE 122 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 123 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 124 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 125 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 126 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IMPACT
10.3 EUROPE
TABLE 127 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 128 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 129 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 130 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 131 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany to dominate European isothermal nucleic acid amplification technology market during forecast period
TABLE 133 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 134 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 135 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 136 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 137 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 UK
10.3.2.1 Growing adoption of INAAT products to support market growth in UK
TABLE 138 NUMBER OF BLOOD DONATIONS IN UK, 2016–2020
TABLE 139 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 140 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 141 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 142 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 143 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Established blood screening regulations to boost growth
TABLE 144 HIV DATA FOR FRANCE, 2021
TABLE 145 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 146 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 147 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 148 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 149 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Favorable government initiatives for blood transfusion to support growth
TABLE 150 HIV DATA FOR ITALY, 2021
TABLE 151 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 152 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 153 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 154 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 155 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing demand for diagnostic testing in Spain to favor market growth
TABLE 156 HIV DATA FOR SPAIN, 2021
TABLE 157 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 158 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 159 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 160 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 161 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 162 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 163 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 164 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 165 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 166 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 EUROPE: RECESSION IMPACT
10.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SNAPSHOT
TABLE 167 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 168 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 169 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 170 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 171 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 172 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China to dominate APAC INAAT market during forecast period
TABLE 173 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 174 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 175 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 176 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Universal healthcare reimbursement policy to drive market growth in Japan
TABLE 178 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 179 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 180 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 181 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Government initiatives for blood donation to contribute to growth
TABLE 183 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 184 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 185 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 186 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 187 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 188 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 189 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 190 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 191 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 192 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 ASIA PACIFIC: RECESSION IMPACT
10.5 LATIN AMERICA
10.5.1 GROWING AWARENESS ABOUT INAAT TO PROPEL GROWTH
TABLE 193 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 194 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 195 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 196 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 197 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 LATIN AMERICA: RECESSION IMPACT
10.6 MIDDLE EAST & AFRICA
10.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
TABLE 198 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 199 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 200 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 201 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 202 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 29 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: STRATEGIES ADOPTED
11.3 REVENUE SHARE ANALYSIS
FIGURE 30 REVENUE ANALYSIS OF KEY COMPANIES (2020–2022)
11.4 MARKET SHARE ANALYSIS
FIGURE 31 MARKET SHARE ANALYSIS OF KEY COMPANIES (2022)
TABLE 203 INAAT MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 32 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX, 2022
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
11.6.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
TABLE 204 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
11.6.2 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 205 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
11.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 206 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
11.7.1 PROGRESSIVE COMPANIES
11.7.2 STARTING BLOCKS
11.7.3 RESPONSIVE COMPANIES
11.7.4 DYNAMIC COMPANIES
FIGURE 33 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES
TABLE 207 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DETAILED LIST OF KEY START-UPS/SMES
TABLE 208 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
11.9 COMPETITIVE SCENARIO AND TRENDS
11.9.1 PRODUCT LAUNCHES
TABLE 209 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: KEY PRODUCT LAUNCHES, JANUARY 2020– JANUARY 2023
11.9.2 DEALS
TABLE 210 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: KEY DEALS, JANUARY 2020–JANUARY 2023
11.9.3 OTHER DEVELOPMENTS
TABLE 211 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: OTHER KEY DEVELOPMENTS, JANUARY 2020–JANUARY 2023
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses & competitive threats)*
12.1.1 HOLOGIC, INC.
TABLE 212 HOLOGIC, INC.: BUSINESS OVERVIEW
FIGURE 34 HOLOGIC, INC.: COMPANY SNAPSHOT (2022)
12.1.2 ABBOTT LABORATORIES
TABLE 213 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 35 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
12.1.3 GRIFOLS, S.A.
TABLE 214 GRIFOLS, S.A.: BUSINESS OVERVIEW
FIGURE 36 GRIFOLS, S.A.: COMPANY SNAPSHOT (2021)
12.1.4 BECTON, DICKINSON AND COMPANY
TABLE 215 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
12.1.5 MERIDIAN BIOSCIENCE
TABLE 216 MERIDIAN BIOSCIENCE: BUSINESS OVERVIEW
FIGURE 38 MERIDIAN BIOSCIENCE: COMPANY SNAPSHOT (2022)
12.1.6 EIKEN CHEMICAL CO., LTD.
TABLE 217 EIKEN CHEMICAL CO., LTD.: BUSINESS OVERVIEW
FIGURE 39 EIKEN CHEMICAL CO., LTD.: COMPANY SNAPSHOT (2021)
12.1.7 QUIDEL CORPORATION
TABLE 218 QUIDEL CORPORATION: BUSINESS OVERVIEW
FIGURE 40 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
12.1.8 QIAGEN N.V.
TABLE 219 QIAGEN N.V.: BUSINESS OVERVIEW
FIGURE 41 QIAGEN N.V.: COMPANY SNAPSHOT (2021)
12.1.9 NEW ENGLAND BIOLABS
TABLE 220 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
12.1.10 DIASORIN S.P.A.
TABLE 221 DIASORIN S.P.A.: BUSINESS OVERVIEW
FIGURE 42 DIASORIN S.P.A.: COMPANY SNAPSHOT (2021)
12.1.11 BIOM?RIEUX SA
TABLE 222 BIOM?RIEUX SA: BUSINESS OVERVIEW
FIGURE 43 BIOM?RIEUX SA: COMPANY SNAPSHOT (2021)
12.1.12 TECAN TRADING GROUP
TABLE 223 TECAN TRADING GROUP: BUSINESS OVERVIEW
FIGURE 44 TECAN TRADING GROUP: COMPANY SNAPSHOT (2021)
12.1.13 GENERAL ELECTRIC COMPANY
TABLE 224 GENERAL ELECTRIC COMPANY: BUSINESS OVERVIEW
FIGURE 45 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2021)
12.1.14 THERMO FISHER SCIENTIFIC
TABLE 225 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 46 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021)
12.1.15 OPTIGENE LIMITED
TABLE 226 OPTIGENE LIMITED: BUSINESS OVERVIEW
12.2 OTHER COMPANIES
12.2.1 LGC LIMITED
12.2.2 USTAR BIOTECHNOLOGIES
12.2.3 TWISTDX LIMITED
12.2.4 MAST GROUP LTD.
12.2.5 GENOMTEC
12.2.6 GENOSENSOR CORPORATION
12.2.7 JENA BIOSCIENCE GMBH
12.2.8 LIFE SCIENCES ADVANCED TECHNOLOGIES
12.2.9 PCR BIOSYSTEMS
12.2.10 ATILA BIOSYSTEMS
*Details on Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses & competitive threats might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 PRIMARY RESEARCH
FIGURE 3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: PRIMARY RESPONDENTS
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY RESOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: CAGR PROJECTIONS, 2023–2028
FIGURE 8 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
2.4 DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT
3 EXECUTIVE SUMMARY
FIGURE 10 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 11 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 12 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 13 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET
4 PREMIUM INSIGHTS
4.1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET OVERVIEW
FIGURE 15 INCREASING PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT AND COUNTRY (2022)
FIGURE 16 ASSAYS, KITS, AND REAGENTS ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SHARE, BY APPLICATION, 2023 VS. 2028
FIGURE 17 DISEASE DIAGNOSIS APPLICATION SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028
4.4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Recent launches of INAAT consumables by prominent market players
5.2.1.2 Growing funding initiatives for molecular diagnostics & infectious disease diagnostics
5.2.1.3 High prevalence of infectious diseases
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable reimbursement scenario for in vitro diagnostic tests
5.2.3 OPPORTUNITIES
5.2.3.1 INAAT tests as point-of-care tools
5.2.3.2 Start-ups focusing on INAAT
5.2.4 CHALLENGES
5.2.4.1 Dominance of PCR
5.3 PRICING ANALYSIS
TABLE 2 AVERAGE SELLING PRICE OF INAAT PRODUCTS, 2022
5.4 VALUE CHAIN ANALYSIS
FIGURE 20 VALUE CHAIN OF INAAT MARKET: MAXIMUM VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.5 ECOSYSTEM ANALYSIS
FIGURE 21 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS
TABLE 3 SUPPLY CHAIN ECOSYSTEM
5.6 KEY CONFERENCES & EVENTS IN 2023–2024
TABLE 4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 5 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT FROM NEW ENTRANTS
5.7.2 THREAT FROM SUBSTITUTES
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 BARGAINING POWER OF SUPPLIERS
5.7.5 DEGREE OF COMPETITION
5.8 KEY STAKEHOLDERS & BUYING CRITERIA
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF INAAT PRODUCTS
FIGURE 23 BUYING CRITERIA FOR INAAT PRODUCTS
5.9 PATENT ANALYSIS
FIGURE 24 PATENT APPLICATIONS RELATED TO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, JANUARY 2012–DECEMBER 2022
5.10 REGULATORY ANALYSIS
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10.1 NORTH AMERICA
5.10.1.1 US
5.10.1.2 Canada
5.10.2 EUROPE
TABLE 10 EUROPE: CLASSIFICATION OF DEVICES
5.10.3 ASIA PACIFIC
5.10.3.1 China
5.10.3.2 Japan
5.10.3.3 India
5.10.4 LATIN AMERICA
5.10.4.1 Brazil
5.10.4.2 Mexico
5.10.5 MIDDLE EAST
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 25 REVENUE SHIFT AND NEW REVENUE POCKETS
6 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 11 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 ASSAYS, KITS, AND REAGENTS
6.2.1 GROWING AWARENESS OF INAAT TO DRIVE DEMAND FOR ASSAYS, KITS, AND REAGENTS
TABLE 12 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 13 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 14 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 15 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 SYSTEMS
6.3.1 GROWING POPULARITY OF INAAT SYSTEMS TO SUPPORT MARKET GROWTH
TABLE 16 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 17 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 20 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGIES
TABLE 21 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
7.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP)
7.2.1 LAUNCH OF NEW LAMP DIAGNOSTIC KITS TO SUPPORT MARKET GROWTH
TABLE 22 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 23 NORTH AMERICA: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 EUROPE: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 ASIA PACIFIC: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)
7.3.1 GROWING EFFORTS TO DEVELOP TMA KITS TO BOOST GROWTH
TABLE 26 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 27 NORTH AMERICA: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 EUROPE: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 29 ASIA PACIFIC: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 NICKING ENZYME AMPLIFICATION REACTION (NEAR)
7.4.1 RAPID IDENTIFICATION OF SMALL DNA OR RNA FRAGMENTS TO BOOST ADOPTION OF NEAR
TABLE 30 NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 31 NORTH AMERICA: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 EUROPE: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 ASIA PACIFIC: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 STRAND DISPLACEMENT AMPLIFICATION (SDA)
7.5.1 GROWING USE OF SDA IN RNA AMPLIFICATION TO PROPEL MARKET GROWTH
TABLE 34 STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 EUROPE: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 ASIA PACIFIC: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.6 HELICASE-DEPENDENT AMPLIFICATION (HDA)
7.6.1 USE OF THERMOSTABLE HELICASE ENZYMES INSTEAD OF HEAT TO BOOST DEMAND FOR HDA
TABLE 38 HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 EUROPE: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 ASIA PACIFIC: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.7 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA)
7.7.1 ADVANTAGES OF NASBA OVER PCR TO BOOST ADOPTION IN CLINICAL SETTINGS
TABLE 42 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 EUROPE: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 ASIA PACIFIC: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.8 SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA)
7.8.1 USE OF RNA/DNA-3? PRIMER FOR FIRST-STRAND CDNA SYNTHESIS TO DRIVE MARKET
TABLE 46 SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 47 NORTH AMERICA: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 EUROPE: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 ASIA PACIFIC: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.9 OTHER TECHNOLOGIES
TABLE 50 OTHER INAAT TECHNOLOGIES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 51 NORTH AMERICA: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 EUROPE: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 ASIA PACIFIC: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 54 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 DISEASE DIAGNOSIS
TABLE 55 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 56 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 57 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 59 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.1 COVID-19
8.2.1.1 Extensive use of INAAT kits for COVID-19 diagnosis to support market growth
TABLE 60 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY REGION, 2021–2028 (USD MILLION)
TABLE 61 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.2 HEPATITIS
8.2.2.1 Growing adoption of advanced technologies for diagnosis of hepatitis B to drive growth
FIGURE 26 NEW CASES OF HEPATITIS B AND HEPATITIS C WORLDWIDE, BY GENDER, 2020
TABLE 64 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY REGION, 2021–2028 (USD MILLION)
TABLE 65 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.3 CT/NG
8.2.3.1 Growing prevalence of CT/NG infections worldwide to boost market
TABLE 68 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY REGION, 2021–2028 (USD MILLION)
TABLE 69 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.4 INFLUENZA
8.2.4.1 Growing focus on containing spread of influenza to propel growth
TABLE 72 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY REGION, 2021–2028 (USD MILLION)
TABLE 73 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.5 HIV
8.2.5.1 High global incidence of HIV to support market growth
TABLE 76 GLOBAL HIV CASES, 2021
TABLE 77 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY REGION, 2021–2028 (USD MILLION)
TABLE 78 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.6 OTHER DISEASES
TABLE 81 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2021–2028 (USD MILLION)
TABLE 82 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 BLOOD SCREENING
8.3.1 INCREASING NUMBER OF BLOOD DONATIONS AND TRANSFUSIONS TO INCREASE USE OF INAAT IN BLOOD SCREENING APPLICATIONS
TABLE 85 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 86 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 OTHER APPLICATIONS
TABLE 89 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 90 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 91 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 92 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
9 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER
9.1 INTRODUCTION
TABLE 93 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 HOSPITALS
9.2.1 HOSPITALS TO DOMINATE INAAT MARKET DURING FORECAST PERIOD
TABLE 94 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION)
TABLE 95 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 96 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 97 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 REFERENCE LABORATORIES
9.3.1 AVAILABILITY OF WIDE RANGE OF TEST PANELS FOR INFECTIOUS DISEASE TESTING TO SUPPORT MARKET
TABLE 98 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 99 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 ACADEMIC & RESEARCH INSTITUTES
9.4.1 GROWING USE OF INAAT ASSAYS BY ACADEMIC & RESEARCH INSTITUTES TO BOOST MARKET
TABLE 102 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 103 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 OTHER END USERS
TABLE 106 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 107 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 108 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 109 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
10 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION
10.1 INTRODUCTION
TABLE 110 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SNAPSHOT
TABLE 111 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 112 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 113 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 114 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 115 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 116 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 Increasing approvals of INAAT products to drive market growth
TABLE 117 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 118 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 119 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 120 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Growing demand for molecular diagnostic kits to boost adoption of INAAT
TABLE 122 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 123 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 124 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 125 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 126 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IMPACT
10.3 EUROPE
TABLE 127 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 128 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 129 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 130 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 131 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany to dominate European isothermal nucleic acid amplification technology market during forecast period
TABLE 133 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 134 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 135 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 136 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 137 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 UK
10.3.2.1 Growing adoption of INAAT products to support market growth in UK
TABLE 138 NUMBER OF BLOOD DONATIONS IN UK, 2016–2020
TABLE 139 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 140 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 141 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 142 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 143 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Established blood screening regulations to boost growth
TABLE 144 HIV DATA FOR FRANCE, 2021
TABLE 145 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 146 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 147 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 148 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 149 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Favorable government initiatives for blood transfusion to support growth
TABLE 150 HIV DATA FOR ITALY, 2021
TABLE 151 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 152 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 153 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 154 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 155 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing demand for diagnostic testing in Spain to favor market growth
TABLE 156 HIV DATA FOR SPAIN, 2021
TABLE 157 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 158 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 159 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 160 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 161 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 162 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 163 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 164 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 165 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 166 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 EUROPE: RECESSION IMPACT
10.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SNAPSHOT
TABLE 167 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 168 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 169 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 170 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 171 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 172 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China to dominate APAC INAAT market during forecast period
TABLE 173 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 174 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 175 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 176 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Universal healthcare reimbursement policy to drive market growth in Japan
TABLE 178 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 179 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 180 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 181 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Government initiatives for blood donation to contribute to growth
TABLE 183 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 184 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 185 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 186 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 187 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 188 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 189 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 190 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 191 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 192 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 ASIA PACIFIC: RECESSION IMPACT
10.5 LATIN AMERICA
10.5.1 GROWING AWARENESS ABOUT INAAT TO PROPEL GROWTH
TABLE 193 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 194 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 195 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 196 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 197 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 LATIN AMERICA: RECESSION IMPACT
10.6 MIDDLE EAST & AFRICA
10.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
TABLE 198 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 199 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 200 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 201 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 202 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 29 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: STRATEGIES ADOPTED
11.3 REVENUE SHARE ANALYSIS
FIGURE 30 REVENUE ANALYSIS OF KEY COMPANIES (2020–2022)
11.4 MARKET SHARE ANALYSIS
FIGURE 31 MARKET SHARE ANALYSIS OF KEY COMPANIES (2022)
TABLE 203 INAAT MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 32 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX, 2022
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
11.6.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
TABLE 204 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
11.6.2 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 205 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
11.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 206 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
11.7.1 PROGRESSIVE COMPANIES
11.7.2 STARTING BLOCKS
11.7.3 RESPONSIVE COMPANIES
11.7.4 DYNAMIC COMPANIES
FIGURE 33 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES
TABLE 207 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DETAILED LIST OF KEY START-UPS/SMES
TABLE 208 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
11.9 COMPETITIVE SCENARIO AND TRENDS
11.9.1 PRODUCT LAUNCHES
TABLE 209 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: KEY PRODUCT LAUNCHES, JANUARY 2020– JANUARY 2023
11.9.2 DEALS
TABLE 210 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: KEY DEALS, JANUARY 2020–JANUARY 2023
11.9.3 OTHER DEVELOPMENTS
TABLE 211 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: OTHER KEY DEVELOPMENTS, JANUARY 2020–JANUARY 2023
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses & competitive threats)*
12.1.1 HOLOGIC, INC.
TABLE 212 HOLOGIC, INC.: BUSINESS OVERVIEW
FIGURE 34 HOLOGIC, INC.: COMPANY SNAPSHOT (2022)
12.1.2 ABBOTT LABORATORIES
TABLE 213 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 35 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
12.1.3 GRIFOLS, S.A.
TABLE 214 GRIFOLS, S.A.: BUSINESS OVERVIEW
FIGURE 36 GRIFOLS, S.A.: COMPANY SNAPSHOT (2021)
12.1.4 BECTON, DICKINSON AND COMPANY
TABLE 215 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
12.1.5 MERIDIAN BIOSCIENCE
TABLE 216 MERIDIAN BIOSCIENCE: BUSINESS OVERVIEW
FIGURE 38 MERIDIAN BIOSCIENCE: COMPANY SNAPSHOT (2022)
12.1.6 EIKEN CHEMICAL CO., LTD.
TABLE 217 EIKEN CHEMICAL CO., LTD.: BUSINESS OVERVIEW
FIGURE 39 EIKEN CHEMICAL CO., LTD.: COMPANY SNAPSHOT (2021)
12.1.7 QUIDEL CORPORATION
TABLE 218 QUIDEL CORPORATION: BUSINESS OVERVIEW
FIGURE 40 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
12.1.8 QIAGEN N.V.
TABLE 219 QIAGEN N.V.: BUSINESS OVERVIEW
FIGURE 41 QIAGEN N.V.: COMPANY SNAPSHOT (2021)
12.1.9 NEW ENGLAND BIOLABS
TABLE 220 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
12.1.10 DIASORIN S.P.A.
TABLE 221 DIASORIN S.P.A.: BUSINESS OVERVIEW
FIGURE 42 DIASORIN S.P.A.: COMPANY SNAPSHOT (2021)
12.1.11 BIOM?RIEUX SA
TABLE 222 BIOM?RIEUX SA: BUSINESS OVERVIEW
FIGURE 43 BIOM?RIEUX SA: COMPANY SNAPSHOT (2021)
12.1.12 TECAN TRADING GROUP
TABLE 223 TECAN TRADING GROUP: BUSINESS OVERVIEW
FIGURE 44 TECAN TRADING GROUP: COMPANY SNAPSHOT (2021)
12.1.13 GENERAL ELECTRIC COMPANY
TABLE 224 GENERAL ELECTRIC COMPANY: BUSINESS OVERVIEW
FIGURE 45 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2021)
12.1.14 THERMO FISHER SCIENTIFIC
TABLE 225 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 46 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021)
12.1.15 OPTIGENE LIMITED
TABLE 226 OPTIGENE LIMITED: BUSINESS OVERVIEW
12.2 OTHER COMPANIES
12.2.1 LGC LIMITED
12.2.2 USTAR BIOTECHNOLOGIES
12.2.3 TWISTDX LIMITED
12.2.4 MAST GROUP LTD.
12.2.5 GENOMTEC
12.2.6 GENOSENSOR CORPORATION
12.2.7 JENA BIOSCIENCE GMBH
12.2.8 LIFE SCIENCES ADVANCED TECHNOLOGIES
12.2.9 PCR BIOSYSTEMS
12.2.10 ATILA BIOSYSTEMS
*Details on Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses & competitive threats might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
